CIAM
BDTX icon

Caitong International Asset Management’s Black Diamond Therapeutics BDTX Stock Holding History

Caitong International Asset Management’s Portfolio BDTX Stock Details BDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$261 Buy
+141
New +$345 ﹤0.01% 1933
2026
Q1 		– Sell
-74
Closed -$180 – 2621
2025
Q4 		$180 Sell
74
-8
-10% -$28 ﹤0.01% 1632
2025
Q3 		$311 Sell
82
-9,106
-99% -$26.6K ﹤0.01% 1616
2025
Q2 		$22.8K Buy
9,188
+5,628
+158% +$10.8K 0.02% 472
2025
Q1 		$5.52K Buy
+3,560
New +$7.46K ﹤0.01% 997

Other funds holding BDTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
DIM
DLK Investment Management Solana Beach, California $235M AUM 12.41% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Caitong International Asset Management's BDTX Position: Q2 2026 in Review

Caitong International Asset Management opened a new position in Black Diamond Therapeutics (BDTX) in Q2 2026: 141 shares worth $261. The stake represents ﹤0.01% of the portfolio and ranks #1933 among its holdings. This is a return to the name: Caitong International Asset Management previously reported a position in BDTX as recently as Q4 2025.

Caitong International Asset Management first reported a position in BDTX in Q1 2025 and has held it in 5 quarters since. The position peaked at $22.8K in Q2 2025. 26 funds tracked by Wall St. Rank hold BDTX as of Q2 2026.

  • Caitong International Asset Management held 141 shares of Black Diamond Therapeutics worth $261 as of Q2 2026.
  • Black Diamond Therapeutics was a new Caitong International Asset Management position in Q2 2026.
  • Black Diamond Therapeutics made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #1933 holding.
  • Caitong International Asset Management first reported a position in Black Diamond Therapeutics in Q1 2025 and has held it in 5 quarters since.
  • Caitong International Asset Management's Black Diamond Therapeutics position peaked at $22.8K in Q2 2025.
  • 26 funds tracked by Wall St. Rank held Black Diamond Therapeutics as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.